NCT06404034 2026-03-04
Expanded Access to Gallium Maltolate (GaM)
Imaging Biometrics, LLC
No longer available
Clinical Trials
25 trialsNCT07223606 2025-11-03
Fecal Microbiota Transplant for Neuroblastoma in a Single Patient
ProgenaBiome
No longer available
NCT04802447 2025-09-16
EAP
Roswell Park Cancer Institute
No longer available
NCT05064306 2025-08-01
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
No longer available
NCT03649438 2024-12-11
131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma
University of Texas Southwestern Medical Center
No longer available
NCT05518838 2024-11-08
Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered
Oblato, Inc.
No longer available
NCT04714086 2024-10-24
Expanded Access Program for Avapritinib
Blueprint Medicines Corporation
No longer available
NCT05936216 2024-10-01
TVI-Brain-1 in Expanded Access Patient
TVAX Biomedical
No longer available
NCT05551013 2024-08-09
Treatment of Recurrent GBM With APG-157 Via Expanded Access
Aveta Biomics, Inc.
No longer available
NCT06439849 2024-07-16
TRIANGLE
Petrov, Andrey
No longer available
NCT04321694 2024-04-25
Expanded Access for KHK2455
Kyowa Kirin Co., Ltd.
No longer available
NCT01838187 2023-08-18
Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma
Children's Hospital Medical Center, Cincinnati
No longer available
NCT02431715 2023-02-21
18F-FDOPA PET in Neuroendocrine Tumours
British Columbia Cancer Agency
No longer available
NCT04599647 2022-06-29
EAP for the Treatment of Glioblastoma With PVSRIPO
Istari Oncology, Inc.
No longer available
NCT05392374 2022-05-26
Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
Jazz Pharmaceuticals
No longer available
NCT02075177 2022-03-21
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
South Plains Oncology Consortium
No longer available
NCT04289155 2022-03-17
Individual Patient Compassionate Use of GX-I7
Genexine, Inc.
No longer available
NCT03134131 2022-03-14
Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline High Grade Gliomas
Jazz Pharmaceuticals
No longer available
NCT03424473 2020-02-25
Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer
Seagen Inc.
No longer available
NCT02589912 2019-12-06
Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients
Massachusetts Eye and Ear Infirmary
No longer available
NCT03460782 2019-11-08
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
Center Trials & Treatment
No longer available
NCT03123952 2019-07-15
Expanded Access to ABT-414
AbbVie
No longer available
NCT03311542 2018-01-10
Expanded Access for Pembrolizumab (MK-3475)
Center Trials & Treatment
No longer available
NCT03068650 2017-10-18
CDX-110
Celldex Therapeutics
No longer available
NCT02755987 2016-06-07
Expanded Access to ANG1005 for Individual Patients
Angiochem Inc
No longer available